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Abstract: Hepatitis E virus (HEV) is one of the causative agents of water-borne human viral hepatitis
and considered in Europe an emerging zoonotic pathogen. Analysis of bottled water through a
standard method validated for HEV can contribute towards the risk management of this hazard.
Putting some recent reports by the European Food Safety Authority in place, this study aimed to
assess the performance of the concentration and extraction procedures described in ISO 15216-1:2017
for norovirus and hepatitis A virus on HEV detection. Following the ISO recommendation, the bottled
water samples were spiked using serially diluted HEV fecal suspensions together with mengovirus
as process control and concentrated by filtration via positively charged nylon membranes. In order to
extract viral RNA from the resulting concentrates, two different methods were compared in this study:
The one recommended in the ISO norm, NucliSens® MiniMag® system (NS), and an alternative
commercially available kit NucleoSpin®RNA virus kit (MN). Finally, three reverse transcription
quantitative PCR (RT-qPCR) assays were used to quantify HEV titers. The evaluated procedures
resulted in average HEV recoveries of 14.08 ± 4.90% and 3.58 ± 0.30% for the MN and NS methods,
respectively. The limit of detection (LoD95%) was 1.25 × 104 IU/L for both extraction methods
combined with the three RT-qPCR assays tested, with the exception of NS extraction coupled with
RT-qPCR1 that showed a LoD95% of 4.26 × 103 IU/L. The method characteristics generated in this
study support the limited suitability of the ISO 15216-1:2017 concentration procedure coupled with
the evaluated RT-qPCR assays for detecting HEV in bottled water.
Keywords: Hepatitis E Virus (HEV); bottled water; concentration method; RT-qPCR
1. Introduction
Hepatitis E virus (HEV) is either a quasi- or non-enveloped, single-stranded, positive-sense RNA
virus that causes acute hepatitis [1]. Globally, it has been estimated that HEV causes 3 million acute
cases and 56,600 HEV-related deaths per year [2]. In Europe, hepatitis E is considered an emerging
infectious disease given the increasing trend of outbreaks in the past decade [3].
HEV causes water- and food-borne diseases with different epidemiology depending on the
geographical region and the circulating genotype. HEV genotype G1 and G2 are responsible for
most of hepatitis E cases in highly endemic areas, causing large outbreaks mostly associated with the
consumption of contaminated water. By contrast, HEV G3 and G4 causes sporadic cases or small
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outbreaks in non-endemic areas, corresponding to low endemic countries [4–6]. Sporadic and epidemic
HEV outbreaks in endemic regions have been mostly caused by waterborne transmission, while the
zoonotic transmission has been demonstrated in developed countries mainly due to the consumption
of raw pork and wild-boar meat [5,7,8].
HEV waterborne outbreaks have occurred in poor sanitation and hygiene practices settings where
the access to drinking water is limited [9–11]. HEV could be transported along all the water cycle by
runoff, drainage, and overland flow, and potentially contaminate surface waters used for drinking
water production [12]. Even though some experimental information supports the effectiveness of
UV and chlorine disinfection treatments against HEV based on the partial reduction of the RNA
copies [13,14], the lack of standardized procedures for HEV detection in bottled water hampers the
development of risk management tools and thus the policy on water safety. Moreover, by applying a
standardized and official method, researchers could generate more useful harmonized data.
Concerning this matter, the European Food Safety Authority (EFSA) recently stated that methods
described in the validated ISO 15216-1:2017 norm to quantify hepatitis A virus (HAV) and human
norovirus genogroup I and II (norovirus GI and GII) [15,16] should be evaluated to demonstrate their
effectiveness for the detection of HEV in bottled water and food matrices [3]. The same agency recently
quoted foodborne viruses and specifically HEV among the topics of the food safety regulatory research
needs 2030 [17]. Therefore, this study aimed to assess the ISO 15216-1:2017 method for detecting HEV
in bottled water as well as some modifications of the procedure and to generate method characteristics
such as the virus recovery efficiencies and the limit of detection.
2. Materials and Methods
2.1. Virus Strains
Human fecal sample containing HEV genotype 3f was used in this study. Fecal sample (10% w/v)
was suspended in phosphate-buffered saline (PBS) containing 2 M NaNO3 (Panreac, Barcelona, Spain),
1% beef extract (Conda, Madrid, Spain), and 0.1% Triton X-100 (Thermo Fisher Scientific, Barcelona,
Spain) (pH 7.2). The mix was then vigorously vortexed and centrifuged at 1000× g for 5 min to obtain
a final 10% (w/v) fecal suspension in PBS. The supernatant was stored at −80 ◦C in 2 mL aliquots.
The first WHO international standard for HEV nucleic acid amplification technique (NAT)-based
assays (code 6329/10) was purchased from Paul-Ehrlich-Institut (Langen, Germany). This standard
corresponds to HEV genotype 3a positive plasma measured in international units and containing
250,000 international units (IU)/mL [18]. Mengovirus (MgV) vMC0 (CECT 100000, Valencia, Spain)
was used as a process control.
2.2. Detection Limit and Efficiency of the Procedure to Concentrate HEV in Bottled Water According to ISO
15216-1:2017
Commercial bottled water samples were artificially inoculated with serially diluted (5, 4, and 3
log10 IU/L) 10% HEV positive fecal suspension. To determine the efficacy of the procedures, and thus
validate the results, bottled water samples were also spiked with titrated MgV (107 PCRU/L) as process
control [15,19]. Two experimental replicates were analyzed for each contamination level. Samples were
then concentrated and processed as described by ISO 15216-1:2017. Briefly, 1 L of bottled water was
inoculated with HEV and filtered through nylon positively charged membrane filter discs with 0.45 µm
pore size and 47 mm diameter (3M Company, Spain) using a vacuum pump. 4 mL Tris-glycine-beef
extract (TGBE) buffer pH 9.5 was used to elute the virus from the filter, 10 mL TGBE to elute the virus
attached to the bottle by shaking 20 min at 50 rpm and 2 mL TGBE to rinse the interior walls of the
bottle by gentle shaking and inversion by hand. All the eluates were pooled, pH adjusted to 7.0 with
HCl and viruses concentrated by ultrafiltration with 30 kDa Amicon® Ultra-15 filter tubes (Merck
Millipore Ltd., Madrid, Spain). Final concentrates were adjusted to 1 mL with PBS and stored at −80 ◦C
until processed. RNA was extracted with either the NucleoSpin®RNA (Macherey-Nagel GmbH & Co.,
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Dueren, Germany) (referred to as MN) or the Nuclisens® MiniMag® (BioMérieux, Barcelona, Spain)
(referred to as NS) kits according to the manufacturer’s instructions as detailed in Section 2.3. For each
method and contamination level, a sample with PBS (i.e., without bottled water) was included in order
to assess potential matrix effects.
2.3. RNA Extraction and RT-qPCR Assays
The MN extraction was performed according to the manufacturer’s instructions with some
modifications. Briefly, 150 µL of each concentrated sample was mixed with 25 µL Plant RNA Isolation
Aid (Thermo Fisher Scientific, Barcelona, Spain) and 600 µL of lysis buffer from the MN kit and
subjected to pulse-vortexing for 1 min. Afterwards, the homogenate was centrifuged for 5 min at
10,000× g to remove the debris. The supernatant was subsequently processed according to the MN
manufacturer’s instructions. The NS extraction was performed according to the manufacturer’s
instructions; sample volume was 500 µL and elution volume was 100 µL.
Resultant RNA was analyzed using the RNA UltraSense One-Step kit (Invitrogen, Barcelona,
Spain) and RT-qPCR performed as described by Schlosser [20] for HEV (referred as RT-qPCR1) and
ISO 15216-1:2017 for MgV. For both assays, undiluted and 1/10 diluted RNA was tested to check for
inhibitors. Moreover, RNAs were also quantified using the CeeramTools® Hepatitis E Virus Detection
KHEV commercial kit (BioMérieux) (referred as RT-qPCR2) provided with an internal amplification
control and a HEV RT-qPCR assay described by Jothikumar [21] and modified by Girón-Callejas [22]
(RT-qPCR3). All samples were run in duplicate and different controls were used, including negative
process, extraction, and RT-qPCR controls.
HEV was quantified by plotting the quantification cycles (Cqs) to an external standard curve
independently built for each RT-qPCR assay with the International Standard WHO HEV RNA (code
6329/10). Relevant RT-qPCR1 and RT-qPCR2 assay characteristics have been reported elsewhere [23].
Standard curve for RT-qPCR3 (y = -3.5008x + 38.564) showed a R2 value of 0.997.
2.4. Statistical Analysis
Results were statistically analyzed, and significance of differences was determined on the ranks
with a one-way analysis of variance (ANOVA) and Tukey’s multiple comparison tests. In all cases,
a value of p < 0.05 was deemed significant. The estimated probability of detection with 95% confidence
(LoD95%) was calculated by using the PODLOD calculation program (version9) [24] for all water
samples, as in [16].
3. Results and Discussion
Limit of Detection and Efficiency of HEV Concentration Procedure in Bottled Water Based on ISO 15216-1:2017
Given the aforementioned regulatory research priorities, the present study aimed to evaluate ISO
15216-1:2017 method for HEV detection in bottled water and to generate method characteristics as the
virus recovery yield and the LoD95%.
To this end, inoculated bottled water samples were processed as described in ISO 15216-1:2017 and
RNA was extracted using two commercially available kits, NucleoSpin®RNA virus kit and NucliSens®
MiniMag® system.
The resultant RNA was analyzed through three different RT-qPCR assays (Table 1): RT-qPCR1
(as described in [20,23], CeeramTools® Hepatitis E Virus Detection HEV commercial kit (RT-qPCR2),
and RT-qPCR3 as described in [21] and modified in [22].
The mean HEV recoveries obtained from the processed bottled water samples were 14.08 ± 4.90%
and 3.58 ± 0.30% for the MN and NS methods, respectively (Figure 1).
Microorganisms 2020, 8, 730 4 of 8
Table 1. Primers and probes used in this study.
Assay Amplification Region Primers and Probe Sequence 5’-3’ RT-qPCR Conditions Location * Reference
RT-qPCR1 ORF3
HEV.Fa GTGCCGGCGGTGGTTTC RT 50 ◦C for 30’
5296–5377
(81 nt)
[20]
Hev.Fb GTGCCGGCGGTGGTTTCTG 95 ◦C for 15’
HEV.R GCGAAGGGGTTGGTTGGATG PCR (45x)
HEV.P FAM-TGACMGGGT/ZEN/TGATTCTCAGCC/3IABkFQ 95 ◦C for 10”
55 ◦C for 20”
72 ◦C for 15”
RT-qPCR2 ORF3 N/A N/A
RT 45 ◦C for 10’
N/A
Ceeram
(hepatitis@ceeramTools)
95 ◦C for 10’
PCR (40x)
95 ◦C for 15”
60 ◦C for 45”
RT-qPCR3 ORF3
JVHEVF GGTGGTTTCTGGGGTGAC RT 50 ◦C for 30’
5304–5373
(69 nt)
[21,22]
JVHEVRmod AGGGGTTGGTTGGRTGRA 95 ◦C for 2’
JVHEVPmod TGATTCTCAGCCCTTCGC PCR (45x)
95 ◦C for 15”
60 ◦C for 40”
F: Forward primer; R: Reverse primer; and P: Probe.* Location in reference to WHO International Standard for HEV RNA, HRC-HE104 strain, accession no. AB630970 [18].
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Figure 1. Hepatitis E virus (HEV) recovery in bottled water samples using the ISO 15216-1:2017 
procedure and comparing two extraction kits and three RT-qPCRs assays. MN: NucleoSpin®RNA 
virus kit (Macherey-Nagel GmbH & Co.); NS: NucliSens® MiniMag® system (BioMerieux SA); 
RT-qPCR1: modified from [20]; RT-qPCR2: CeeramTools® Hepatitis E Virus Detection KHEV kit 
(BioMérieux SA); and RT-qPCR3: Described in [21] and modified in [22]. Different letters denote 
significant differences among methods for each virus (p < 0.05). 
The MN method rendered a LoD95% of 1.25 × 104 IU/L for all the RT-qPCR assays, while the NS 
extraction coupled with RT-qPCR1 rendered a slightly lower LoD95% of 4.26 × 103 IU/L (Table 2).  
Table 2. Limit of detection of HEV in bottled water according to ISO 15216-1:2017 virus 
concentration procedure and comparing two extraction kits and three RT-qPCRs assays. 
Extraction Method RT-qPCR Levels of Inoculated HEV (IU/L)  LoD95%
a 
(IU/L) 1 × 105 1 × 104 1 × 103  
MN 
RT-qPCR1 4/4b 4/4 0/4  1.25 × 104 
RT-qPCR2 4/4 4/4 0/4  1.25 × 104 
RT-qPCR3 4/4 4/4 0/4  1.25 × 104 
NS 
RT-qPCR1 4/4 4/4 2/4  4.26 × 103 
RT-qPCR2 4/4 4/4 0/4  1.25 × 104 
RT-qPCR3 4/4 4/4 0/4  1.25 × 104 
a Calculated according to (24); b HEV positive/total numbers of samples. 
A minimum recovery rate of 1% MgV was obtained for all the samples, thus validating the 
results according to the criteria stated in ISO 15216-1:2017. Additional analytical determination 
should be performed by spiking purified HEV virus, since the fecal material used in the study is 
expected to contain defective particles and free RNA that may have negatively contributed to 
calculate the recoveries. Despite NS extraction showed lower HEV recoveries, it resulted more 
sensitive due to lower LoD95%. 
Although HEV LoD95% in bottled water are not available, those obtained in this study are 
somehow higher compared to the ones reported for HAV and norovirus in the method validation. 
For instance, LoD95% of 1.80 × 102, 7.00 × 101, and 4.00 × 102 copies/L have been reported for norovirus 
GI, norovirus GII, and HAV, respectively [16]. 
These discrepancies could be partially explained by the different dilution series used in the 
validation study (0.5 log10) [16] compared to those in the present study (1 log10).  
Figure 1. Hepatitis E virus (HEV) recovery in bottled water samples using the ISO 15216-1:2017
procedure and comparing two extraction kits and three RT-qPCRs assays. MN: NucleoSpin®RNA virus
kit (Macherey-Nagel GmbH & Co.); NS: NucliSens® MiniMag® system (BioMerieux SA); RT-qPCR1:
modified from [20]; RT-qPCR2: CeeramTools® Hepatitis E Virus Detection KHEV kit (BioMérieux SA);
and RT-qPCR3: Described in [21] and modified in [22]. Different letters denote significant differences
among methods for each virus (p < 0.05).
The MN method rendered a LoD95% of 1.25 × 104 IU/L for all the RT-qPCR assays, while the NS
extraction coupled with RT-qPCR1 rendered a slightly lower LoD95% of 4.26 × 103 IU/L (Table 2).
Table 2. Limit of detection of HEV in bottled water according to ISO 15216-1:2017 virus concentration
procedure and comparing two extraction kits and three RT-qPCRs assays.
Extraction Method RT-qPCR
Levels of Inoculated HEV (IU/L) LoD95%a
(IU/L)1 × 105 1 × 104 1 × 103
MN
RT-qPCR1 4/4 b 4/4 0/4 1.25 × 104
RT-qPCR2 4/4 4/4 0/4 1.25 × 104
RT-qPCR3 4/4 4/4 0/4 1.25 × 104
NS
RT-qPCR1 4/ 4/4 2/4 4.26 × 103
RT-qPCR2 4/ 4/4 0/4 1.25 × 104
RT-qPCR3 4/4 4/4 0/4 1.25 × 104
a Ca culated according to (2 ; positive/to al numbers of samples.
A minimum recov ry rate of 1% MgV was obtained for all the samples, thus validating the
results according to the criter a stated in ISO 15216-1:2017. Additional analytical det rmi ation should
be erformed by spiking purified HEV virus, since the fecal material used in the study is exp cted
to contain d fective particles and free RNA that may have negatively contributed to calculate th
recoveri s. Despite NS extraction showed lower HEV recoveries, it resulted more sensitive due to
lower LoD95%.
Although HEV LoD95% in bottled wat r are not available, those obta ned i is study are someh w
higher compared to the ones reported for HAV and norovirus n the method validation. For instance,
LoD95% of 1.80 × 102, 7.00 × 101, and 4.00 × 102 copies/L have been reported for norovirus GI, norovirus
GII, and HAV, res ectiv ly [16].
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These discrepancies could be partially explained by the different dilution series used in the
validation study (0.5 log10) [16] compared to those in the present study (1 log10).
Furthermore, to compare the efficiencies of MN and NS extraction kits, we adjusted the final
concentrated volume to 1 mL instead of 500 µL as indicated in the ISO 15216-1:2017.
Despite reaching acceptable recovery values, this has certainly determined a decrease in the
sensitivity of the assay by increasing the LoD95%. Comparing the LoD95% values determined in this
study for HEV in bottled water (approximately 103-104 gc/L) with the ones in wastewater (approximately
105-106 gc/L), effluent (approximately 104 gc/L), and drinking water (approximately 103 gc/L) [25],
the effect of the complexity (i.e., turbidity, volume of the sample) of the water matrix results evident.
Our results on the better performance of MN extraction resemble the previously reported recovery
rates ranging from 16.6% to 36.6% obtained by using a dead end hollow fiber ultrafiltration (DEUF)
combined with polyethylene glycol (PEG) precipitation to concentrate HEV spiked into 20 L drinking
water [25].
Beside the overall performances of the concentration methods, these results confirm the higher
sensitivity of RT-qPCR1 compared to RT-qPCR3, as previously reported for the detection of HEV in
suspension containing the WHO international standard, in human fecal and serum samples, and in
naturally contaminated sewage samples [23]. Similarly, RT-qPCR1 showed to be more sensitive in
detecting HEV in spiked sewage samples, even RT-qPCR3 with a modified probe finally resulted the
best option for wastewater monitoring in a one-year surveillance study [25].
Since RT-qPCR3 detects HEV genotypes one to six and RT-qPCR1 has been initially designed for
porcine HEV-3, the efficiency of the RT-qPCR assays should be tested by mixing in drinking water
different HEV genotypes. However, given the variability of HEV genotypes [26], the RT-qPCR assays
used for naturally contaminated samples must be carefully checked to avoid false negative results and
maybe primer-independent assays should be preferred (i.e., non targeted NGS techniques).
Previous results support DEUF coupled with PEG as an effective method for HEV concentration
in large volume sample of drinking water [25] and it may represent a valuable alternative given the
limited sensitivity and efficiency of the ISO method reported in this study.
Finally, this study generated experimental data to characterize ISO method 15216-1:2017
performance when adapted to analyze HEV in bottled water, such as virus recovery efficiency
and the limit of detection (LoD95%).
4. Conclusions
HEV is considered an emerging pathogen in high-income countries, especially in Europe, and
analytical procedures for estimating HEV concentrations in water samples are required.
The method characteristics generated in this study support the limited suitability of the ISO
15216-1:2017 concentration procedure for recovering HEV in bottled water, even some modifications
such as the reduction of the final concentrate volume could foster the overall analytic performance of
the method.
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